MILLER STRATEGIES, LLC

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Health Issues

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.